Survivin splice variants and their diagnostic significance

Survivin beyond physiology: Orchestration of multistep carcinogenesis and therapeutic potentials

(2014) Kalliopi Ch. Athanasoula et al.   CANCER LETTERS

Survivin as a Preferential Target for Cancer Therapy

(2014) Mahsa Mobahat et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Survivin-2B promotes autophagy by accumulating IKK alpha in the nucleus of selenite-treated NB4 cells

(2014) K Shi et al.   Cell Death & Disease

Clinico-pathologic relevance of Survivin splice variant expression in cancer

(2013) Rosalia de Necochea-Campion et al.   CANCER LETTERS

Survivin-3B Potentiates Immune Escape in Cancer but Also Inhibits the Toxicity of Cancer Chemotherapy

(2013) F. Vegran et al.   CANCER RESEARCH

Transcriptional Expression Analysis of Survivin Splice Variants Reveals Differential Expression of Survivin-3α in Breast Cancer

(2013) Solmaz Moniri Javadhesari et al.   Genetic Testing and Molecular Biomarkers

Cytoplasmic localization of wild-type survivin is associated with constitutive activation of the PI3K/Akt signaling pathway and represents a favorable prognostic factor in patients with acute myeloid leukemia

(2013) J. Serrano-Lopez et al.   HAEMATOLOGICA

Transcriptional regulation of the survivin gene

(2013) Romain Boidot et al.   MOLECULAR BIOLOGY REPORTS

Transcriptional inhibition of p21WAF1/CIP1 gene (CDKN1) expression by survivin is at least partially p53-dependent: Evidence for survivin acting as a transcription factor or co-factor

(2012) Lei Tang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Targeting survivin in cancer

(2012) Dario C. Altieri   CANCER LETTERS

Chk2 Phosphorylation of Survivin- Ex3 Contributes to a DNA Damage-Sensing Checkpoint in Cancer

(2012) A. Lopergolo et al.   CANCER RESEARCH

Marked upregulation of Survivin and Aurora-B kinase is associated with disease progression in the myelodysplastic syndromes

(2012) A. Yoshida et al.   HAEMATOLOGICA

Survivin isoform Delta Ex3 regulates tumor spheroid formation

(2011) Magali Espinosa et al.   CANCER LETTERS

Silencing Survivin Splice Variant 2B Leads to Antitumor Activity in Taxane-Resistant Ovarian Cancer

(2011) P. E. Vivas-Mejia et al.   CLINICAL CANCER RESEARCH

Apoptosis gene signature of Survivin and its splice variant expression in breast carcinoma

(2011) Frédérique Végran et al.   ENDOCRINE-RELATED CANCER

Survivin-deltaEx3: A novel biomarker for diagnosis of papillary thyroid carcinoma

(2011) Esmaeil Babaei et al.   Journal of Cancer Research and Therapeutics

Expression and prognostic significance of survivin splice variants in diffusely infiltrating astrocytoma

(2011) Y. Huang et al.   JOURNAL OF CLINICAL PATHOLOGY

Expression of the Epigenetic factor BORIS (CTCFL) in the Human Genome

(2011) Rosalia de Necochea-Campion et al.   Journal of Translational Medicine

Targeting survivin and p53 in pediatric acute lymphoblastic leukemia

(2011) J W Tyner et al.   LEUKEMIA

CTCF-promoted RNA polymerase II pausing links DNA methylation to splicing

(2011) Sanjeev Shukla et al.   NATURE

Mechanisms of estrogen receptor antagonism toward p53 and its implications in breast cancer therapeutic response and stem cell regulation

(2010) S. D. Konduri et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Aurora B kinase activation requires survivin priming phosphorylation by PLK1

(2010) Youjun Chu et al.   Journal of Molecular Cell Biology

Spliceosome Structure and Function

(2010) C. L. Will et al.   Cold Spring Harbor Perspectives in Biology

Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics

(2008) A. C. Mita et al.   CLINICAL CANCER RESEARCH

Epigenetic and genetic analysis of the survivin promoter in acute myeloid leukemia

(2008) Mandy Wagner et al.   LEUKEMIA RESEARCH